Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient

Key Clinical Message Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlie...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anthony D. Honigman, Francis Lai, Joshua Elakis, Owen Prall, Michelle Goh, Christopher McCormack
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2019-04-01
Schriftenreihe:	Clinical Case Reports
Schlagworte:	granulomatous panniculitis immunotherapy PD‐1 inhibitor Pembrolizumab
Online-Zugang:	https://doi.org/10.1002/ccr3.2090
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!